Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ecohair is a topical botanical hair growth treatment formulated from a combination of extracts of *Coffea arabica* (coffee) and *Larrea divaricata* (Jarilla). Developed in Argentina through a public-private partnership between the National Scientific and Technical Research Council (CONICET) and Laboratorio Garré Guevara, it is used to treat various forms of noncicatricial hair loss, including androgenetic alopecia and alopecia areata. The product is also marketed for enhancing the thickness and growth of eyelashes and eyebrows. Its mechanism of action is attributed to the synergistic antioxidant and stimulating properties of its botanical components, which aim to increase hair volume and reduce hair loss without the systemic side effects typically associated with synthetic hair growth drugs. It is currently being investigated in clinical trials for the prevention of chemotherapy-induced alopecia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ecohair.